Albany, NY -- (SBWire) -- 01/05/2018 --A large number of player are taking part in the global constipation treatment market, which a very common disorder seen amongst people since long time. With increasing activities of research and development and with the help of latest treatment processes and drugs, the key players in the global market are aiming to bring maximum relief to the patients, and thus has led to the opening up of numerous lucrative opportunities for them. Some of the key players in the global market for constipation treatment include names such as Bayer AG, Sucampo Pharmaceuticals Inc., Takeda Pharmaceuticals Company Limited, Ironwood Pharmaceuticals, Inc., aleant Pharmaceuticals International, Inc., Synergy Pharmaceuticals, Inc., Ironwood Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Abbott Laboratories, AstraZeneca, Daewoong Pharmaceuticals Co. Ltd., Prestige Brands Holdings, Inc., Cosmo Pharmaceuticals NV, Janssen Pharmaceutical Company, Albireo Pharma, Inc., and Shionogi & Co., Ltd., Renexxion, LLC among others.

Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/constipation-treatment-market.html

The global market for constipation treatment was valued at US$12.58 bn in the year 2016. This valuation was expected to grow and reach an overall figure worth US$22.93 bn by the end of 2025. This growth of the global market is expected to be achieved with the help of a strong CAGR of 7.1% over the course of the given forecast period of 2017 to 2025. Depend of the therapeutic alternatives, the global market for constipation treatment generates maximum demand for the segment of laxative, which can be further sub-segmented into osmotic laxatives, stimulant laxatives, and bulk forming agents. The segment of laxative is projected to witness an incremental demand at an impressive CAGR of 7.0% over the course of the given forecast period of 2017 to 205, thanks to the low prices and easy availability.

Depending on the type of disease, the global market for constipation treatment has been dominated by the segment of opioid induced constipation, while hospitals are expected to continue their dominance as the most important channel of distribution. In terms of geography, North America is the most lucrative market, though Asia Pacific is expected to show most promising growth rate and generate numerous business opportunities.

Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16442

Constipation is a very common disorder amongst masses, and is experienced by nearly each individual at some stage of their life, if not regularly, and it is evident in a range of 8% to 32.5% of populace across the world. The choice of treatment or medicine depends on the constipation type. One of the key factors responsible for the overall growth of the global constipation treatment market is the growing population of older people across the world. In addition to this, constantly changing dietary habits is also seen to be another important driving factor for the growth of the market. It is projected the over half of the people above the age of 50 are vulnerable to have chronic constipation. Furthermore, leading players in the industry are investing heavily on the development of new treatment drugs for constipation, which is expected to fuel the overall growth of the market.

However, there are some factors that might impede the growth of the global market in the coming years of forecast period. One of the key restraining factor is considered to be the consistent reliance on over the counter (OTC) drugs and on generic laxatives as well. Moreover, the specialty constipation drugs have not yet reached all over the world as expected. This is also expected to slow down the growth of the market.

Purchase this Report: https://www.transparencymarketresearch.com